1177 related articles for article (PubMed ID: 27658884)
21. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.
Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812
[TBL] [Abstract][Full Text] [Related]
22. Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia.
Rana S; Cerdeira AS; Wenger J; Salahuddin S; Lim KH; Ralston SJ; Thadhani RI; Karumanchi SA
PLoS One; 2012; 7(10):e48259. PubMed ID: 23110221
[TBL] [Abstract][Full Text] [Related]
23. Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.
Chaiworapongsa T; Romero R; Korzeniewski SJ; Kusanovic JP; Soto E; Lam J; Dong Z; Than NG; Yeo L; Hernandez-Andrade E; Conde-Agudelo A; Hassan SS
Am J Obstet Gynecol; 2013 Apr; 208(4):287.e1-287.e15. PubMed ID: 23333542
[TBL] [Abstract][Full Text] [Related]
24. Angiogenic factors and preeclampsia.
Tjoa ML; Levine RJ; Karumanchi SA
Front Biosci; 2007 Jan; 12():2395-402. PubMed ID: 17127249
[TBL] [Abstract][Full Text] [Related]
25. [Serum soluble Endoglin, plasma endothelin-1 and coagulation function in early onset severe preeclampsia with organ dysfunction].
Zhang LJ; Han YH; Han YZ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Jun; 22(6):371-4. PubMed ID: 20594474
[TBL] [Abstract][Full Text] [Related]
26. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.
Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083
[TBL] [Abstract][Full Text] [Related]
27. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio.
Buhimschi CS; Baumbusch MA; Dulay AT; Lee S; Wehrum M; Zhao G; Bahtiyar MO; Pettker CM; Ali UA; Funai EF; Buhimschi IA
BJOG; 2010 Feb; 117(3):321-30. PubMed ID: 19943826
[TBL] [Abstract][Full Text] [Related]
28. sFlt-1 and soluble endoglin concentrations in serum vs plasma in preterm preeclampsia: Are they interchangeable for biomarker studies?
Brownfoot F; Kaitu'u-Lino T; Beard S; Tong S; Hannan N
Pregnancy Hypertens; 2017 Oct; 10():18-21. PubMed ID: 29153675
[TBL] [Abstract][Full Text] [Related]
29. Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset.
Hirashima C; Ohkuchi A; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
Hypertens Res; 2008 Aug; 31(8):1541-8. PubMed ID: 18971528
[TBL] [Abstract][Full Text] [Related]
30. [Association between plasma levels of soluble leukocyte differentiation antigens CD₄₀/CD₄₀ ligand and kidney damage in preeclamptic patients].
Qin W; Zhan Y; Ye YH; Li C; Cui XN
Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):582-6. PubMed ID: 22169515
[TBL] [Abstract][Full Text] [Related]
31. Angiogenic factors for the prediction of preeclampsia in high-risk women.
Moore Simas TA; Crawford SL; Solitro MJ; Frost SC; Meyer BA; Maynard SE
Am J Obstet Gynecol; 2007 Sep; 197(3):244.e1-8. PubMed ID: 17826405
[TBL] [Abstract][Full Text] [Related]
32. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.
Rana S; Karumanchi SA; Levine RJ; Venkatesha S; Rauh-Hain JA; Tamez H; Thadhani R
Hypertension; 2007 Jul; 50(1):137-42. PubMed ID: 17515455
[TBL] [Abstract][Full Text] [Related]
33. Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia.
Chedraui P; Lockwood CJ; Schatz F; Buchwalder LF; Schwager G; Guerrero C; Escobar GS; Hidalgo L
J Matern Fetal Neonatal Med; 2009 Jul; 22(7):565-70. PubMed ID: 19350449
[TBL] [Abstract][Full Text] [Related]
34. Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women.
Levine RJ; Qian C; Maynard SE; Yu KF; Epstein FH; Karumanchi SA
Am J Obstet Gynecol; 2006 Apr; 194(4):1034-41. PubMed ID: 16580293
[TBL] [Abstract][Full Text] [Related]
35. The diagnosis values of serum STAT4 and sEng in preeclampsia.
Zhang L; Li X; Zhou C; You Z; Zhang J; Cao G
J Clin Lab Anal; 2020 Feb; 34(2):e23073. PubMed ID: 31628681
[TBL] [Abstract][Full Text] [Related]
36. Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia.
Rădulescu C; Bacârea A; Huțanu A; Gabor R; Dobreanu M
Mediators Inflamm; 2016; 2016():3027363. PubMed ID: 27799724
[TBL] [Abstract][Full Text] [Related]
37. Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia.
Lim JH; Kim SY; Park SY; Lee MH; Yang JH; Kim MY; Chung JH; Lee SW; Ryu HM
Prenat Diagn; 2009 May; 29(5):471-6. PubMed ID: 19253312
[TBL] [Abstract][Full Text] [Related]
38. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
Aggarwal PK; Chandel N; Jain V; Jha V
J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
[TBL] [Abstract][Full Text] [Related]
39. [Study on p38 mitogen activated protein kinase in vascular endothelial cells dysfunction in preeclampsia].
Luo X; Liu DD; Qi HB; Yao ZW
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):36-40. PubMed ID: 21429433
[TBL] [Abstract][Full Text] [Related]
40. Association of increased cord blood soluble endoglin with the development of bronchopulmonary dysplasia in preterm infants with maternal preeclampsia.
Kim DH; Shin SH; Kim EK; Kim HS
Pregnancy Hypertens; 2018 Jul; 13():148-153. PubMed ID: 30177044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]